Slate Path Capital LP
- SEC CIK
- 0001559706
- Latest filing
- Aug 14, 2026
KRSA holding history
Korsana Biosciences, Inc. in every 13F filed by Slate Path Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KRSA overviewAll 13F holders of KRSAFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −357,880−100.0% | Sold out | Holders |
| Q3 2024 | 357,880 | $926.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 357,880 | $823.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 357,880 | $1.15M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 357,880 | $1.20M | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 357,880 | $1.22M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 357,880 | $1.47M | 0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | Holders |
| Q1 2023 | 7,157,601 | $3.11M | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 7,157,601 | $4.70M | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2022 | 7,157,601 | $6.16M | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2022 | 7,157,601 | $3.93M | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2022 | 7,157,601 | $7.95M | 0.4% | 00.0% | Unchanged | Holders |
| Q4 2021 | 7,157,601 | $12.3M | 0.6% | 00.0% | Unchanged | Holders |
| Q3 2021 | 7,157,601 | $22.0M | 1.0% | 00.0% | Unchanged | Holders |
| Q2 2021 | 7,157,601 | $27.9M | 1.6% | +961,538+15.5% | Added | Holders |
| Q1 2021 | 6,196,063 | $17.3M | 1.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.